NEW YORK, Feb. 18, 2014 /PRNewswire/ -- Tripp Levy PLLC, a leading securities and shareholder rights law firm that represents shareholders throughout the nation, announces that it is investigating the offer to acquire Chindex International Inc. (CHDX) relating to the proposed acquisition by a buyer consortium led by an affiliate of TPG, and including an affiliate of Shanghai Fosun Pharmaceutical Group Co., Ltd., and Chindex CEO Roberta Lipson ("Consortium").
Under the terms of the transaction, Chindex shareholders will receive only $19.50 in cash for each share of Chindex stock they own. The investigation concerns possible breaches of fiduciary duty and other violations of state law by the Senior Management and Board of Directors of Chindex for not acting in the Company's shareholders' best interests in connection with the sale process. The investigation seeks to determine if the Chindex Board of Directors failed to conduct an adequate auction process and if the Consortium is underpaying for Chindex. In addition, the investigation seeks to determine if conflicts of interest played a role as the Chindex CEO is part of the Consortium purchasing the Company.
If you are a shareholder of Chindex and would like additional information regarding this matter, at no cost or expense, please contact us at:
Tripp Levy PLLC
New York, New York
Toll free: 1-877-772-3975
Tripp Levy PLLC is a leading securities and shareholder rights law firm that has extensive experience in mergers and takeovers, and has assisted in the recovery of hundreds of millions of dollars for shareholders around the globe. Attorney advertising. Prior results do not indicate a similar outcome
SOURCE Tripp Levy PLLC